August 30, 2026
“This article first appeared on GuruFocus. …Release Date: August 03, 2026″ https://finance.yahoo.com/markets/stocks/articles/palantir-technologies-inc-pltr-q2-050456686.html Click link to view full article.

August 30, 2026
“This article first appeared on GuruFocus. …Release Date: August 03, 2026″ https://finance.yahoo.com/markets/stocks/articles/palantir-technologies-inc-pltr-q2-050456686.html Click link to view full article.
February 19, 2026
“… …” https://finance.yahoo.com/news/2-undervalued-ai-stocks-buy-093200646.html Side note: When I share these articles that doesn’t mean I agree or disagree with with these people are saying. My opinion is neutral unless I say otherwise.
January 26, 2026
“…Acumen Pharmaceuticals (ABOS)… With a major catalyst ahead and ABOS shares trading at $1.98, Stifel’s 5-star analyst Paul Matteis thinks now is the right time to make a move… To this end, Matteis rates ABOS a Buy, and his $10 price… Continue Reading…
January 24, 2026
“Billionaires Cliff Asness, Israel Englander, and Steven Cohen — three highly successful hedge fund managers — purchased shares of Nvidia and Western Digital during the third quarter… Wall Street estimates Nvidia’s adjusted earnings will increase at 67% annually through the… Continue Reading…
December 10, 2025
“Goldmans Sachs has agreed to buy Innovator Capital Management, a provider of defined-outcome ETFs, for about $2 billion. Innovator had $28 billion of assets under supervision across 159 ETFs as of Sept. 30. Goldman Sachs has made asset and wealth… Continue Reading…
October 1, 2024
“…UiPath: 212% implied upside… Going forward, Wall Street expects UiPath to grow sales at 10% annually through fiscal 2026 (ends April 2026). That estimate leaves room for upside because the RPA market is forecasted to grow at 40% annually through… Continue Reading…
September 4, 2024
“…COMPASS Pathways (CMPS)… Morgan Stanley analyst Vikram Purohit, who covers the stock, sees CMPS as presenting a compelling risk-reward opportunity. He highlights the company’s leading clinical program… To this end, Purohit rates CMPS shares an Overweight (i.e. Buy), and his $23 price… Continue Reading…
August 27, 2024
https://www.bitchute.com/video/dhFar968Pf3J I got a little behind with the Financial news. When so much happens all at once I get a little behind. I had to watch / catchup with the shows. I linked shared 5 different videos in total. They’re… Continue Reading…
Recent Comments